Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.35
-$0.015-0.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 96.09M | 250.40M | -44.97M | 85.13M | 81.67M |
| Total Depreciation and Amortization | 58.98M | -- | 116.06M | -59.96M | 62.20M |
| Total Amortization of Deferred Charges | 7.13M | -- | 14.09M | -7.32M | 4.30M |
| Total Other Non-Cash Items | 817.96M | -786.20M | 640.72M | -581.31M | 738.44M |
| Change in Net Operating Assets | -911.00M | -- | -142.90M | 743.01M | -734.52M |
| Cash from Operations | 69.16M | -535.81M | 583.00M | 179.55M | 152.10M |
| Capital Expenditure | -37.44M | -31.14M | -43.95M | -34.55M | -33.96M |
| Sale of Property, Plant, and Equipment | 790.40K | 20.50K | 180.20K | 43.00K | 93.40K |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | -216.20K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -514.34M | -70.43M | -195.91M | -10.91M | -467.43M |
| Cash from Investing | -550.98M | -101.55M | -239.68M | -45.42M | -501.51M |
| Total Debt Issued | 3.89B | 4.31B | 1.45B | 1.44B | 1.81B |
| Total Debt Repaid | -2.52B | -3.13B | -2.46B | -963.99M | -1.97B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -90.70M | -11.55M | -106.92M | -36.60M | -157.78M |
| Other Financing Activities | 182.67M | -64.08M | 188.86M | -220.92M | -42.60M |
| Cash from Financing | 123.43M | 141.03M | -221.53M | -1.09M | -185.68M |
| Foreign Exchange rate Adjustments | -118.70K | 870.00K | 295.50K | 101.90K | 255.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -358.50M | -495.46M | 122.09M | 133.15M | -534.83M |